1. N Ahmed,J Khan,T Siddiqui (2008). Frequency of dyslipidaemia in type 2 diabetes mellitus in patients of Hazara division. J Ayub Med Coll Abbottabad, 20, 51-54.
2. A American Diabetes (2010). Standards of Medical Care in Diabetes—2010. Diabetes Care, 33(Supplement_1), S11-S61.
3. G Bozkaya,E Ozgu,B Karaca (2010). The association between estimated average glucose levels and fasting plasma glucose levels. Clinics, 65, 1077-1080.
4. Alireza Esteghamati,Mehrshad Abbasi,Manouchehr Nakhjavani,Abbas Yousefizadeh,Amelita Basa,Hamid Afshar (2006). Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovascular Diabetology, 5(1), 15.
5. S Haffner (1998). Management of dyslipidemia in adults with diabetes. Diabetes Care, 21, 160-178.
6. Steven Haffner,Seppo Lehto,Tapani Rönnemaa,Kalevi Pyörälä,Markku Laakso (1998). Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New England Journal of Medicine, 339(4), 229-234.
7. Chikako Ito,Ryo Maeda,Sakurako Ishida,Hideo Sasaki,Hisako Harada (2000). Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Research and Clinical Practice, 50(3), 225-230.
8. H Khan,S Sobki,S Khan (2007). Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clinical and experimental medicine, 7, 24-29.
9. S Lehto,T Ronnemaa,S Haffner,K Pyorala,V Kallio,M Laakso (1997). Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes, 46(8), 1354-1359.
10. G Lowe,A Lee,A Rumley,J Price,F Fowkes (1997). Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. British Journal of Haematology, 96(1), 168-173.
11. A Marcus (2001). Lipid disorders in patients with type 2 diabetes. Meeting the challenges of early, aggressive treatment. Postgrad Med, 110, 111-114.
12. Addisu Mengesha (2006). Lipid profile among diabetes patients in Gaborone, Botswana. Journal of Endocrinology, Metabolism and Diabetes of South Africa, 11(1), 32-34.
13. D Nathan,H Turgeon,S Regan (2007). Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia, 50(11), 2239-2244.
14. K Pyorala,M Laakso,M Uusitupa (1987). Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev, 3, 463-524.
15. C Rohlfing,H.-M Wiedmeyer,R Little,J England,A Tennill,D Goldstein (2002). Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care, 25, 275-278.
16. D Sacks,D Bruns,D Goldstein,N Maclaren,J Mcdonald,M Parrott (2002). Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem, 48, 436-472.
17. T Temelkova-Kurktschiev,M Hanefeld (2004). The Lipid Triad in Type 2 Diabetes - Prevalence and Relevance of Hypertriglyceridaemia/Low High-Density Lipoprotein Syndrome in Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes, 112(02), 75-79.
18. World Health,Organization Noncommunicable,Surveillance (1999). Definition, diagnosis and classification of diabetes mellitus and its complications : report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. Definition, diagnosis and classification of diabetes mellitus and its complications : report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus
